Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control

New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus AUSTIN, Texas--(BUSINESS WIRE)-- Asuragen, Inc. has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic. Asuragen’s proprietary Armor [...]

March 16th, 2020|News|